PL1765310T3 - Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków - Google Patents
Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związkówInfo
- Publication number
- PL1765310T3 PL1765310T3 PL05826138T PL05826138T PL1765310T3 PL 1765310 T3 PL1765310 T3 PL 1765310T3 PL 05826138 T PL05826138 T PL 05826138T PL 05826138 T PL05826138 T PL 05826138T PL 1765310 T3 PL1765310 T3 PL 1765310T3
- Authority
- PL
- Poland
- Prior art keywords
- mixture
- low
- high molecular
- transdermal administration
- molecular compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2004/017169 WO2005039464A1 (en) | 2003-10-10 | 2004-05-28 | Transdermal high and low molecular weight compounds |
| US10/856,567 US7220427B2 (en) | 1998-07-08 | 2004-05-28 | Mixture for transdermal delivery of low and high molecular weight compounds |
| EP05826138.9A EP1765310B1 (en) | 2004-05-28 | 2005-05-25 | A mixture for transdermal delivery of low and high molecular weight compounds |
| PCT/US2005/019017 WO2006041538A2 (en) | 2004-05-28 | 2005-05-25 | A mixture for transdermal delivery of low and high molecular weight compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1765310T3 true PL1765310T3 (pl) | 2016-04-29 |
Family
ID=36148757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05826138T PL1765310T3 (pl) | 2004-05-28 | 2005-05-25 | Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1765310B1 (pl) |
| CA (1) | CA2566354C (pl) |
| PL (1) | PL1765310T3 (pl) |
| WO (1) | WO2006041538A2 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1971362T3 (en) | 2005-08-19 | 2015-01-26 | Amylin Pharmaceuticals Llc | Exendin for treating diabetes and reducing body weight |
| US20110263496A1 (en) | 2008-05-21 | 2011-10-27 | Amylin Pharmaceuticals, Inc. | Exendins to lower cholesterol and triglycerides |
| EP2938324B1 (en) | 2012-12-31 | 2023-11-08 | JRX Biotechnology, Inc. | Liquid topical pharmaceutical nano-emulsion formulations |
| EP3349717A4 (en) | 2015-09-17 | 2019-04-17 | JRX Biotechnology, Inc. | APPROACHES TO IMPROVE SKIN HYDROGENATION OR HUMIDIFICATION |
| JP7159052B2 (ja) | 2016-04-08 | 2022-10-24 | ローディア オペレーションズ | パーソナルケア組成物及び該組成物の使用方法 |
| RU2762896C2 (ru) | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
| CA3047354A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| EP3644973B1 (en) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
| IL277766B2 (en) * | 2018-05-09 | 2024-12-01 | Nestle Sa | Composition for coating frozen confectionery and a process for manufacturing same |
| CN110958876B (zh) | 2018-06-20 | 2020-12-18 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| DE102021119031B4 (de) | 2021-07-22 | 2024-08-08 | Manfred Lotz | Behandlung von Polymyalgia Rheumatica |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3829641A1 (de) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | Transdermal anwendbare pharmazeutische zubereitungen mit sterolinen und/oder spiroketalinen |
| US5318960A (en) * | 1992-06-03 | 1994-06-07 | Frank Toppo | System for transdermal delivery of pain relieving substances |
| US6946144B1 (en) * | 1998-07-08 | 2005-09-20 | Oryxe | Transdermal delivery system |
| US6656499B1 (en) * | 1999-11-12 | 2003-12-02 | Pharmaderm Laboratories, Ltd. | Composition for transdermal and dermal administration of interferon-α |
-
2005
- 2005-05-25 EP EP05826138.9A patent/EP1765310B1/en not_active Expired - Lifetime
- 2005-05-25 CA CA2566354A patent/CA2566354C/en not_active Expired - Lifetime
- 2005-05-25 PL PL05826138T patent/PL1765310T3/pl unknown
- 2005-05-25 WO PCT/US2005/019017 patent/WO2006041538A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2566354C (en) | 2016-01-12 |
| WO2006041538A3 (en) | 2007-06-07 |
| EP1765310A4 (en) | 2012-07-04 |
| WO2006041538A2 (en) | 2006-04-20 |
| CA2566354A1 (en) | 2006-04-20 |
| EP1765310A2 (en) | 2007-03-28 |
| EP1765310B1 (en) | 2015-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1799865A4 (en) | PROCESS FOR THE ADMINISTRATION OF ILOPERIDONE | |
| CY2014011I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| SMP200700023B (it) | Dispositivi e metodi per iniezioni di medicinali | |
| DK2292219T3 (da) | Transdermalt terapeutisk system til administration af rivastigmin | |
| ATE442131T1 (de) | Stabilisierte supergesättigte feste lísungen von steroidalen arzneimitteln | |
| LTC1761540I2 (lt) | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai | |
| EP1827298A4 (en) | THERAPEUTIC APPARATUS FOR IMPROVING THE PROTECTIVE EFFECTS OF POST-CONDITIONING ORGANS | |
| DK2158905T3 (da) | Sammensætning til transdermal administration af fentanyl | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| EP1891597A4 (en) | UNIFIED MANAGEMENT, DISTRIBUTION, ADMINISTRATION AND IMAGING OF RADIOPHARMACEUTICAL AGENT | |
| NO20073482L (no) | Fremgangsmåte til å stabilisere antidement medikament | |
| ECSP077238A (es) | Composiciones para entrega de drogas altamente solubles en agua | |
| EP1513825A4 (en) | ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS | |
| ATE425952T1 (de) | (biphenyl)carbonsauren und derivate davon | |
| DK1701698T3 (da) | Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779 | |
| EP1752150A4 (en) | Irinotecan PREPARATION | |
| DK2063881T3 (da) | Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer | |
| PL1765310T3 (pl) | Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków | |
| EP1796676A4 (en) | TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES | |
| GB0524958D0 (en) | Transdermal administration of active agents | |
| BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
| BRPI0912038A2 (pt) | composto, mistura, composição farmacêutica, uso do composto, e, métodos para tratar e evitar uma infecção por picornavírus, e para formar o composto | |
| SM200400022B (it) | Composti farmaceutici transdermici | |
| ATE401870T1 (de) | Transdermales therapeutisches system zur verabreichung von analgetika | |
| SE0400685D0 (sv) | Means for transdermal administration of nicotine |